Norges Bank Axonics, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$66.47 - $69.65 $84.5 Million - $88.6 Million
1,271,656 New
1,271,656 $85.5 Million
Q4 2023

Feb 09, 2024
BUY
$49.38 - $63.75 $29.9 Million - $38.6 Million
604,931 New
604,931 $37.6 Million
Q3 2023

Nov 13, 2024
BUY
$48.64 - $62.51 $63 Million - $81 Million
1,296,097 New
1,296,097 $72.7 Million
Q3 2023

Nov 13, 2023
SELL
$48.64 - $62.51 $54.2 Million - $69.7 Million
-1,114,927 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$47.99 - $60.21 $2.07 Million - $2.59 Million
43,044 Added 3.38%
1,314,700 $66.4 Million
Q2 2023

Aug 14, 2023
SELL
$47.99 - $60.21 $52.5 Million - $65.8 Million
-1,093,319 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$52.6 - $67.34 $67.6 Million - $86.5 Million
1,285,070 New
1,285,070 $70.1 Million
Q4 2022

Feb 14, 2023
BUY
$59.56 - $76.6 $72.8 Million - $93.6 Million
1,222,450 New
1,222,450 $76.4 Million
Q3 2022

Nov 13, 2023
BUY
$57.96 - $78.12 $64.6 Million - $87.1 Million
1,114,927 New
1,114,927 $78.5 Million
Q2 2022

Aug 14, 2023
BUY
$39.5 - $64.42 $43.2 Million - $70.4 Million
1,093,319 New
1,093,319 $62 Million
Q1 2022

May 12, 2023
SELL
$43.74 - $62.76 $32.6 Million - $46.8 Million
-746,003 Reduced 61.03%
476,447 $29.8 Million
Q1 2022

May 09, 2022
SELL
$43.74 - $62.76 $17.8 Million - $25.6 Million
-407,745 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$50.01 - $73.35 $20.4 Million - $29.9 Million
407,745 New
407,745 $22.8 Million
Q3 2021

Nov 14, 2022
BUY
$59.21 - $78.66 $24.1 Million - $32.1 Million
407,745 New
407,745 $26.5 Million
Q3 2021

Nov 05, 2021
SELL
$59.21 - $78.66 $17.1 Million - $22.7 Million
-289,043 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$51.39 - $66.9 $14.9 Million - $19.3 Million
289,043 New
289,043 $18.3 Million
Q2 2021

Aug 10, 2021
SELL
$51.39 - $66.9 $14.9 Million - $19.3 Million
-289,043 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$49.14 - $59.89 $14.2 Million - $17.3 Million
289,043 New
289,043 $17.3 Million
Q1 2021

May 07, 2021
SELL
$49.14 - $59.89 $17.8 Million - $21.6 Million
-361,304 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$42.19 - $51.5 $15.2 Million - $18.6 Million
361,304 New
361,304 $18 Million
Q4 2020

Feb 10, 2021
SELL
$42.19 - $51.5 $19.4 Million - $23.7 Million
-459,439 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$35.33 - $51.04 $16.2 Million - $23.4 Million
459,439 New
459,439 $23.5 Million
Q3 2020

Nov 10, 2020
SELL
$35.33 - $51.04 $16.2 Million - $23.4 Million
-459,439 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$22.91 - $39.83 $10.5 Million - $18.3 Million
459,439 New
459,439 $16.1 Million
Q2 2020

Aug 07, 2020
SELL
$22.91 - $39.83 $10.7 Million - $18.6 Million
-466,863 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$16.44 - $37.73 $7.68 Million - $17.6 Million
466,863 New
466,863 $11.9 Million

Others Institutions Holding AXNX

# of Institutions
234
Shares Held
42.1M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email